Anzeige
Mehr »
Login
Donnerstag, 27.03.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Trump-Dekret entfesselt Kupfer-Boom - ist DAS der nächste +2.000?%-Explorer?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JHKZ | ISIN: US6026701010 | Ticker-Symbol: N/A
1-Jahres-Chart
CTT PHARMACEUTICAL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
CTT PHARMACEUTICAL HOLDINGS INC 5-Tage-Chart
ACCESS Newswire
202 Leser
Artikel bewerten:
(1)

CTT Pharmaceutical Holdings, Inc.: CTT Pharma Gives Update On NSF Grant

Finanznachrichten News

TAMPA, FL / ACCESS Newswire / February 12, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) submitted a full proposal to the National Science Foundation(NSF) for our patented fast dissolving nicotine strips. The NSF grant program is highly competitive as it receives over 12,000 applicants annually from companies that have innovations that could help society. CTT successfully made it past the first round process and is among a few thousand remaining applicants. These remaining applicants have several deadlines over the course of the year to file a full proposal into the grant program. CTT is anticipating an answer in this program in late April. Acceptance into this program would give government backing to CTT Pharma and would allow for extensive research and testing to help lead to development of our technology.

The World Health Organization states, "The tobacco epidemic is one of the biggest public health threats the world has ever faced, killing over 8 million people a year around the world. More than 7 million of those deaths are results of direct tobacco use while 1.3 million are the result of non-smokers being exposed to second-hand smoke." Furthermore, the CDC says, "Cigarette smoking is the leading cause of preventable death in the United States. Cigarette smoking causes more than 480,000 deaths each year in the United States. This is nearly 1 in 5 deaths.

The CEO of CTT Pharma, Ryan Khouri stated, "To make it past the first round of applicants is a huge accomplishment by itself and shows that the NSF sees potential value for our technology within the tobacco industry. Currently there are no fast dissolving, low dose nicotine strips on the market, as most oral products stay in the mouth for an excessive amount of time. CTT also brought someone onto our team to help with this NSF Grant as they have a tremendous amount of experience with the NSF."

CTT will continue to update shareholders as more news becomes available.

CTT Pharma - 813-606-0060

SOURCE: CTT Pharmaceutical Holdings, Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.